-
ISP Pharmaceuticals Announces SOLUBILITY TWENTY TENDaylong Seminars Held in Basel, Amsterdam and Cork in May Will Focus on Ingredient and Processing Technology to Improve Solubility and Bioavailability of Drug Actives Köln, Ge2010/3/17
-
Ranbaxy Announces Settlement Of Actos(R) (Pioglitazone Hydrochloride) Patent LitigationJacksonville, FL -- /PRNewswire/ -- Ranbaxy Laboratories Limited, along with its wholly owned subsidiary Ranbaxy Pharmaceuticals Inc. (collectively, "Ranbaxy"), announced today that they have reached2010/3/17
-
Incorporation of Physical-Chemical Identifiers into Solid Oral Dosage Form Drug Products for Anticounterfeiting20100316.rar source: web of FDA2010/3/16
-
Bayer HealthCare Pharma Receives ODD For Ciprofloxacin Dry Powder InhalerBayer HealthCare Pharma has received orphan drug designation from FDA for ciprofloxacin dry powder inhaler (DPI) which is used in the management of pulmonary infection due to Pseudomonas aeruginosa in2010/3/15
-
Dow Coating Materials Presents Designed Diffusion Technology for VOC Reduction at Furniture Coatings Conference in BerlinHORGEN, Switzerland--(BUSINESS WIRE)--Dow Coating Materials will present a technical paper on the use of “Designed Diffusion” technology to reduce volatile organic compounds (VOCs) in hybrid acrylic/u2010/3/15
-
BASF's crop protection pipeline offers strong growth potential· Value up by €100 million · Kixor™ and boscalid lead growth · AgCelence® with F 500® pioneers a whole new market segment To keep crops healthy and maximize yields on limited farm2010/3/15
-
Polyplus-transfection Licenses ZNA Oligonucleotide Technology to MetabionPolyplus-transfection SA, a company developing innovative solutions for molecular and cellular biology, recently announced that Metabion GmbH, a company specializing in custom synthesis of bio2010/3/12
-
Unilife & sanofi-aventis Agree to Exclusivity List for Unifill RTF SyringeUnilife Corporation recently announced it has agreed to a list of therapeutic drug classes within which sanofi-aventis has the exclusive right to purchase the Unifill ready-to-fill syringe. Sa2010/3/11
-
Pantec Biosolutions Successfully Delivers Largest Protein TransdermallyPantec Biosolutions AG, a privately owned company developing innovative transdermal drug delivery products, recently announced it has achieved excellent results in a Phase I clinical trial of2010/3/11
-
Merrion Pharmaceuticals Granted Pivotal US Patent on GIPET TechnologyUnderscoring the innovation leadership of its GIPET (Gastrointestinal Permeation Enhancement Technology) drug delivery technology, Merrion Pharmaceuticals plc, an international specialty pharm2010/3/11